IBPClin - Instituto Brasil de Pesquisa Clínica
Rio De Janeiro, Brazil
Medical center in Rio de Janeiro, State of Rio de Janeiro
R. da Glória, 344 - Glória, Rio de Janeiro - RJ, 20241-180
About IBPClin - Instituto Brasil de Pesquisa Clínica
"O IBPClin um Centro de Pesquisa Clínica, dedicado à condução de grandes estudos multicêntricos para desenvolvimento de novos medicamentos para a indústria farmacêutica."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
10
Pfizer
4
Amgen
2
Hoffmann-La Roche
2
Anji Pharma
1
Janssen Research & Development, LLC
1
Janssen Vaccines & Prevention B.V.
1
Clinical Trials at IBPClin - Instituto Brasil de Pesquisa Clínica
During the past decade, IBPClin - Instituto Brasil de Pesquisa Clínica conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 4 clinical trials were completed, i.e. on
average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
2018-06-11
2020-10-07
Completed
1,235
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-11-20
2021-11-15
Completed
214
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
2019-07-08
2024-05-27
Active, not recruiting
546
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
2019-05-24
2026-05-22
Recruiting
465
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "IBPClin - Instituto Brasil de Pesquisa Clínica" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Pfizer" with 4 trials
sponsored, "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Anji Pharma"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "IBPClin - Instituto Brasil de Pesquisa Clínica"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at IBPClin - Instituto Brasil de Pesquisa Clínica
According to Clinical.Site data, the most researched conditions in "IBPClin - Instituto Brasil de Pesquisa Clínica" are
"Obesity" (5 trials), "Overweight" (4 trials), "COVID-19" (2 trials), "Crohn Disease" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "IBPClin - Instituto Brasil de Pesquisa Clínica" in a lesser frequency.
Clinical Trials Intervention Types at IBPClin - Instituto Brasil de Pesquisa Clínica
Most popular intervention types in "IBPClin - Instituto Brasil de Pesquisa Clínica" are "Drug" (19 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Tirzepatide" (7 trials), "Baricitinib" (2 trials), "Etrolizumab" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at IBPClin - Instituto Brasil de Pesquisa Clínica
The vast majority of trials in "IBPClin - Instituto Brasil de Pesquisa Clínica" are
21 trials for "All" genders.
Clinical Trials Status at IBPClin - Instituto Brasil de Pesquisa Clínica
Currently, there are NaN active trials in "IBPClin - Instituto Brasil de Pesquisa Clínica".
undefined are not yet recruiting,
6 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in IBPClin - Instituto Brasil de Pesquisa Clínica,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in IBPClin - Instituto Brasil de Pesquisa Clínica, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".